Senior insider sale
See Remarks at SPYRE THERAPEUTICS, INC. — senior position signals high conviction
$4.17M
46.66K shares
What this filing means
KING-JONES HEIDY plans to sell 46.66K shares of SPYRE THERAPEUTICS, INC. valued at approximately $4.17M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/1/2026ACC: 0001950047-26-008970
Officer· See Remarks
Since Sep 2023
46.66K
Shares to sell
$4.17M
Approx. market value
46.66K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
9/1/2026
46.66KTotal acquired46.66K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2026 | Exercise of Stock Options Cash | 46.66K | — |
| Total | 46.66K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
46.66K
Market value
$4.17M
9/1/2026
Total
Units
46.66K
Value
$4.17M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/1/2026 | 46.66K | $4.17M | NASDAQ | Planned |
| Total | 46.66K | $4.17M | ||